Pharmaceutical Preparations · DE · CIK 1937993
Advancing novel therapies for life-threatening immune and thrombotic conditions, focusing on CAD-1005 for HIT
Comparable business profile · signals at a glance
In the 90 days to Dec 29, 2025: 2 sold $298K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 29, 2025 | Szot Matthew KChief Financial Officer | Sell | 9,933 | $6.97 | $69K |
| Oct 27, 2025 | Szot Matthew KChief Financial Officer | Sell | 1,800 | $13.99 | $25K |
| Oct 27, 2025 | Pham Quang XCEO and Chairman | Sell | 1,315 | $13.99 | $18K |
| Oct 24, 2025 | Szot Matthew KChief Financial Officer | Sell | 1,800 | $13.99 | $25K |
| Oct 24, 2025 | Pham Quang XCEO and Chairman | Sell | 1,129 | $14.03 | $16K |
| Oct 13, 2025 | Pham Quang XCEO and Chairman | Sell | 1,800 | $14.15 | $25K |
| Oct 13, 2025 | Szot Matthew KChief Financial Officer | Sell | 1,800 | $14.07 | $25K |
| Oct 9, 2025 | Pham Quang XCEO and Chairman | Sell | 1,800 | $14.02 | $25K |
| Oct 9, 2025 | Szot Matthew KChief Financial Officer | Sell | 1,693 | $13.99 | $24K |
| Oct 6, 2025 | Szot Matthew KChief Financial Officer | Sell | 107 | $13.99 | $1K |
| Oct 2, 2025 | Pham Quang XCEO and Chairman | Sell | 500 | $14.13 | $7K |
| Oct 1, 2025 | Szot Matthew KChief Financial Officer | Sell | 1,700 | $13.99 | $24K |
| Oct 1, 2025 | Pham Quang XCEO and Chairman | Sell | 881 | $14.01 | $12K |
| Sep 29, 2025 | Pham Quang XCEO and Chairman | Sell | 419 | $14.01 | $6K |
| Sep 29, 2025 | Szot Matthew KChief Financial Officer | Sell | 100 | $14.00 | $1K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.